Products

ledvir
Ledvir
14/03/2018
Myvelpa
MyVelpa
14/03/2018
Show all

Hepcinat LP

Hepcinat LP is a fixed-dose combination tablet containing Ledipasvir 90mg and Sofosbuvir 400 mg for oral administration used with or without ribavirin for the treatment of chronic (lasting a long time) hepatitis C virus (HCV) genotype 1, 4, 5 or 6 infection.

Category:
Description

Hepcinat LP is to be administered under the strict supervision of a Hepatologist only. An extra patient leaflet is available with ledipasvir and sofosbuvir. Talk to your pharmacist if you have questions about this information.

  • Hepcinat LP is to be taken by adults over 18 years of age only.
  • Hepcinat LP is to be taken orally with a full glass of water.
  • Hepcinat LP Can be tacken with or without food.
  • The maximum recommended dosing frequency is once per day.
  • To be taken at the same time every day (24 hour gap).
  • Hepcinat LP’s length of treatment may vary for a period between 8 weeks to 24 weeks.
  • Do not stop use and intake of other anti-viral medications alongside Hepcinat LP unless instructed by your doctor.

Important – The correct dosage and prescription commonly depend on the patient and the condition being treated. Duration of dosage can range between 8 weeks to 24 weeks and the correct duration of treatment is to be determined by your medical practitioner or doctor as it will depend on the patient’s condition and their response to the therapy. Do not adjust your dosage without the approval of your medical practitioner or doctor. This product is only for use as prescribed and instructed by a doctor or medical practitioner.